Shire Agrees to Conduct Trials of Vyvanse in ADHD Kids

Shire plc announced that it has agreed to a written request by the Food and Drug Administration (FDA) to conduct pediatric clinical studies to investigate the potential use of Vyvanse (lisdexamfetamine dimesylate) for the treatment of Attention-Deficit ...



from Meta Search Alerts http://ift.tt/1qEn2Zt

via IFTTT